PMID: 15331844Aug 28, 2004Paper

Policy challenges in malaria vaccine introduction

The American Journal of Tropical Medicine and Hygiene
Melinda Moree, Sarah Ewart

Abstract

Recently licensed life-saving vaccines have experienced slow introduction and gradual uptake in the developing world. Policy challenges at the national level contribute to the delay in making new vaccines accessible to people in poor countries. The hurdles that delayed the introduction of other vaccines can provide guidance for navigating the policy challenges that face the introduction of a new malaria vaccine. When a malaria vaccine is licensed, national leaders will rely on available data and analyses to draw conclusions about which malaria interventions have the greatest potential for public health impact. Epidemiologic and economic analyses can help facilitate their decision-making. This article draws attention to the importance of research to inform policy decisions and to minimize delays in the introduction of a new malaria vaccine.

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Immunological Reviews
Jeffrey M BethonyPeter J Hotez
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
W T McGivney
Critical Care : the Official Journal of the Critical Care Forum
Charles D Gomersall
© 2021 Meta ULC. All rights reserved